Dated 4/20/99 just got posted at the Lehman
They are raising their target price. Also state that
IDPH will be presenting data at ASCO on Rituxan in
combo with chemotherapy as first-line treatment. Sounds
The chart pattern shows increased accumulation.
However, new highs often trigger sales targets for some
investors. The stock seems to have spent enough time around
55 to shake out those shares priced at that level
and clear the road ahead for a continued advance.
But, ironically, stock sales later today and tomorrow
by those fearing missing this new price high will
likely cap the upside short term and may even cause a
price decline before resuming IDPH's strong uptrend.
Continue to anticipate strong Q2 earnings, IDEC is
executing its strategy flawlessly.
I'm still here, but, again, I am very tempted to
put a stop in at 60 to watch it drop to 56 and bounce
back up...I am resisting the urge right now, because
IDPH is looking very strong (it continues to make new
highs at each move up)...I am hoping for something
Good luck...Keep holding
Your just stringing us along...
Lets hear the
I'm out for now but may get back in soon. Technicals
still bullish on this company and may be more upside
before earnings announcement in July.
this stock is thinly traded and therefore not much
upside after the deal announcement. After all,
non-hodgkins lymphoma is a relatively small market for a
pharmaceutical company. But it is a great drug and the right
approach for treating cancer.
Ill bet if more
people heard about that jucy stuff the price would
What do you guys think about the news? Didn't
move the stock much, did you end up selling or
holding? Still haven't told me what you'd do with the
money if you did sell. Hope you didn't buy any internet
stocks, they're way off their all time highs, not right
near one like this company is. Don't know why we can't
get past 60, any ideas?
PS that's not even the juiciest news, just wait...